Task: Answer the multiple choice question.
Question: Which compound exhibits a -7.242% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CCOP(=S)(OCC)Oc1cc(C)oc(=O)c1
b Cc1ccccc1/C=N/Nc1ccc(Cl)nn1
c Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1
d CC1(c2cccc(Br)c2)NC(=O)N(CC(=O)NC2CCCCC2)C1=O
Answer: d. CC1(c2cccc(Br)c2)NC(=O)N(CC(=O)NC2CCCCC2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(c2cccc(Br)c2)NC(=O)N(CC(=O)NC2CCCCC2)C1=O
CC1(c2cccc(Br)c2)NC(=O)N(CC(=O)NC2CCCCC2)C1=O
2-[4-(3-bromophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-N-cyclohexylacetamide